RxDoctor Payments Data

Keisha Brown

Child & Adolescent Psychiatry · Tucker, GANPI 1093938276

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Lundbeck LLC at 24.9% of the total. Reporting peaked in 2021 at $837 and has fallen 97.1% since, to $24 in 2024.

$2,574in general payments, 2019–2025

Across 152 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$641
  • AbbVie$633
  • Takeda Pharmaceuticals U.S.A., Inc.$260
  • Sunovion Pharmaceuticals Inc.$240
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$185
  • Supernus Pharmaceuticals, Inc.$152
  • plus $464 from 10 others

What the payments were for

  • Food & beverage$2,51498%
  • Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,574 in reported general payments places this provider in the 80th percentile of 91 child & adolescent psychiatry providers in Georgia.

See all child & adolescent psychiatry providers in Georgia

Other child & adolescent psychiatry in Tucker

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →